CDH13 and gastric cancer: Inhibition of H19 has been shown to repress MMP9, vimentin, E-cadherin, and CDH13 expression in retinoblastoma [113], colorectal, and gastric cancers [114], thereby contributing to epithelial to mesenchymal transition progression [76].